SANGAMO THERAPEUTICS, INC (SGMOQ)
Clinical trial NCT04628871 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2030-01-01 → 2026-06-17 3. primary completion date: 2030-01-01 → 2026-06-17 4. enrollment type: ESTIMATED → ACTUAL
📉 **NEGATIVE** • Medium confidence analysis (68%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (21%) **Content type:** Clinical